REQUEST A DEMO
Total
USD $0.00
Search more companies

Primecell Bioscience, A.S. (Czech Republic)

Main Activities: Corporate, Subsidiary, and Regional Managing Offices
Full name: Primecell Bioscience, A.S. Profile Updated: May 02, 2024
Buy our report for this company USD 19.99 Most recent financial data: 2020 Available in: English Download a sample report

Primecell Bioscience, A.S. is based in Czech Republic, with the head office in Ostrava. The company operates in the Corporate, Subsidiary, and Regional Managing Offices industry. The company was established on September 12, 2016. It currently has a total number of 10 - 19 (2023) employees. There was a net sales revenue increase of 2.82% reported in Primecell Bioscience, A.S.’s latest financial highlights for 2020. Its’ total assets recorded a negative growth of 3.2%. The net profit margin of Primecell Bioscience, A.S. decreased by 29.33% in 2020.

Headquarters
Dr. Slabihoudka 6232/11
Ostrava; Moravskoslezsky; Postal Code: 70800

Contact Details: Purchase the Primecell Bioscience, A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Primecell Bioscience, A.S. report to view the information.
Outstanding Shares:
Purchase the Primecell Bioscience, A.S. report to view the information.
Registered Capital:
Purchase the Primecell Bioscience, A.S. report to view the information.
Incorporation Date:
September 12, 2016
Key Executives
Purchase this report to view the information.
Chairman of the Board of Directors
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Member of the Supervisory Board
Company Performance
Financial values in the chart are available after Primecell Bioscience, A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
2.82%
Total operating revenue
87.55%
Operating profit (EBIT)
-108.41%
EBITDA
-29.58%
Net Profit (Loss) for the Period
-171.19%
Total assets
-3.2%
Total equity
-13.1%
Operating Profit Margin (ROS)
-25.33%
Net Profit Margin
-29.33%
Return on Equity (ROE)
-3.64%
Debt to Equity Ratio
4.04%
Quick Ratio
-0.13%
Cash Ratio
-0.07%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?